Growth hormone response during oral glucose tolerance test: the impact of assay method on the estimation of reference values in patients with acromegaly and in healthy controls, and the role of gender, age, and body mass index.
about
Mass spectrometry - an alternative in growth hormone measurementFactors associated with biochemical remission after microscopic transsphenoidal surgery for acromegaly.Growth hormone nadir during oral glucose load depends on waist circumference, gender and age: normative data in 231 healthy subjects.Serum proteome changes in acromegalic patients following transsphenoidal surgery: novel biomarkers of disease activity.The endocrine tumor summit 2008: appraising therapeutic approaches for acromegaly and carcinoid syndrome.Whole-body insulin sensitivity rather than body-mass-index determines fasting and post-glucose-load growth hormone concentrations.Reevaluation of Acromegalic Patients in Long-Term Remission according to Newly Proposed Consensus Criteria for Control of DiseaseClinical manifestations and diagnosis of acromegalyMedical therapy of acromegalyMonitoring of acromegaly: what should be performed when GH and IGF-1 levels are discrepant?What is active acromegaly and which parameters do we have?Octreotide long-acting repeatable for acromegaly.The changing face of acromegaly--advances in diagnosis and treatment.Growth hormone granulation pattern and somatostatin receptor subtype 2A correlate with postoperative somatostatin receptor ligand response in acromegaly: a large single center experience.Diagnosis of acromegaly: state of the art.Discordance between growth hormone and insulin-like growth factor-1 after pituitary surgery for acromegaly: a stepwise approach and management.The ongoing challenge of discrepant growth hormone and insulin-like growth factor I results in the evaluation of treated acromegalic patients: a systematic review and meta-analysis.Somatostatin receptor ligands in acromegaly: clinical response and factors predicting resistance.Biochemical investigations in diagnosis and follow up of acromegaly.Harmonisation of growth hormone assays in australasia.Long-Term Endocrine Outcomes Following Endoscopic Endonasal Transsphenoidal Surgery for Acromegaly and Associated Prognostic Factors.Nadir growth hormone after oral glucose overload in obese subjects.Prevalence of double pituitary adenomas in a surgical series: Clinical, histological and genetic features.Biochemical diagnosis and assessment of disease activity in acromegaly: a two-decade experience.Growth hormone after oral glucose overload: revision of reference values in normal subjects.Discordant growth hormone and IGF-1 levels post pituitary surgery in patients with acromegaly naïve to medical therapy and radiation: what to follow, GH or IGF-1 values?Long-term follow-up of patients with elevated IGF-1 and nadir GH > 0.4 µg/L but < 1 µg/L.Growth hormone values after an oral glucose load do not add clinically useful information in patients with acromegaly on long-term somatostatin receptor ligand treatment.Diagnosis of acromegaly: black, white… and sometimes gray!Frailty status and altered dynamics of circulating energy metabolism hormones after oral glucose in older women.Postoperative Changes in Metabolic Parameters of Patients with Surgically Controlled Acromegaly: Assessment of New Stringent Cure Criteria.A novel mass spectrometry-based method for determining insulin-like growth factor 1: assessment in a cohort of subjects with newly diagnosed acromegaly.Daily life reflections of acromegaly guidelines.Gender dependence of serum soluble Klotho in acromegaly.Comparison of oral glucose tolerance test (OGTT) 100 g with OGTT 75 g for evaluation of acromegalic patients and the impact of gender on test reproducibilityUpdates in Diagnosis and Treatment of Acromegaly
P2860
Q26865253-C1700DBE-9F15-4ADF-BC1D-7FC8B1EDBBB8Q30408371-0E717117-39B1-43D8-B418-E3BEC1B25083Q33739766-D46DFEAC-8090-49B0-ACD9-54BEDDF87F8FQ33817041-F850FBBB-4D6C-42E5-A977-7F39CADADBFAQ34031906-2741E08C-F47A-4272-8028-65E365D586A4Q34724411-36E26547-A37E-4DCD-B9B9-E545A10D143AQ34815007-65746727-C039-40FA-9146-BCA21A2C7DE8Q35810485-487E759B-1F81-40E0-99A7-5E8C6EC1C424Q35895856-C88CD194-55C5-4BDD-8BEB-CE2C28900C6CQ36845980-BB8A45C1-3D0F-42CF-BA98-587CA62DF92EQ37977989-4A96D6A1-2B30-46DA-A465-C83F2DFB68DEQ37990556-31FBD56A-50BD-42CF-AE30-82318A85E5F8Q38021680-9D55AA54-5913-49BF-B19B-E1F4796B25C6Q38062852-7750A7CA-7791-4259-B28F-EB3B7F81C852Q38131055-67D2C315-1941-46C6-84B5-0CD347B8212FQ38185306-D98EE29B-CD8C-47BD-8DD7-94E33E50021FQ38862772-AD62F88A-7599-4A49-9F5A-4BFCAF2818FEQ38990078-B90473D6-32B6-47B1-97AC-A193604D6F83Q39123579-C428ABED-9503-4F5F-B261-5A75F509F87BQ42321361-3DD9AE8B-4F3C-4C1E-8CCD-CE9C6BC5FF45Q42507980-E251ADBF-5850-4ED7-801C-8925D7BFAED7Q42943088-7773CD6B-AF93-44AA-90A4-97BD1819EC10Q44261839-D81402F0-251C-481D-B342-85467A7A56D2Q45912383-1A7A139B-8125-4AB9-9255-53111B81CD60Q46198507-37319162-966F-4F59-979A-B52B62E0D6F3Q48766407-FFF25FD3-7229-49BF-A37F-D1C223A6DE9FQ49610748-44E5B675-0736-49DA-A451-875FA0428B49Q50884057-9933E624-DD13-4142-A813-B836B65117D6Q51257686-835FC644-2712-4260-80DE-43B9C7D304B3Q51350146-A2144EBA-BA47-4841-954F-65B915D0A545Q52686126-1E005668-F7B4-4B6A-BBFB-17DA60111CCCQ53121310-AB87618D-ED7C-4A84-A40D-FDBF8B53D56DQ53765411-FA9FF4E9-05BC-4839-892D-E806BC113791Q54471311-56B7799A-AD29-47AB-94F4-30CD90A2FF42Q56962774-5EC60151-3992-4F81-BBBA-D867895F3C43Q57822729-BBDFCBA5-6D38-4A46-852F-C91C5999C398
P2860
Growth hormone response during oral glucose tolerance test: the impact of assay method on the estimation of reference values in patients with acromegaly and in healthy controls, and the role of gender, age, and body mass index.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Growth hormone response during ...... der, age, and body mass index.
@en
Growth hormone response during ...... der, age, and body mass index.
@nl
type
label
Growth hormone response during ...... der, age, and body mass index.
@en
Growth hormone response during ...... der, age, and body mass index.
@nl
prefLabel
Growth hormone response during ...... der, age, and body mass index.
@en
Growth hormone response during ...... der, age, and body mass index.
@nl
P2093
P50
P356
P1476
Growth hormone response during ...... nder, age, and body mass index
@en
P2093
Christian J Strasburger
Christof Schöfl
Frank H Perschel
Johannes Purschwitz
P304
P356
10.1210/JC.2007-2084
P407
P577
2008-01-02T00:00:00Z